Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • JManuelMonroyKuhn
    Member
    • Oct 2014
    • 25

    Oases/Velvet error memory

    Hello!

    I was running Oases/Velvet with this command

    python /home/hpc/uj502/di29kiz/oases_0.2.8/scripts/oases_pipeline.py -m 35 -M 45 -s 2 -o '/naslx/projects/uj502/di29kiz/oases/LA2750' -d '-fastq -shortPaired -separate /naslx/projects/uj502/di29kiz/libraries/NG-7404_LA2750tpool1p.fastq /naslx/projects/uj502/di29kiz/libraries/NG-7404_LA2750tpool2p.fastq' -p '-ins_length 229'

    but I got this error

    velvetg: Can't calloc 18446744071712318997 Annotations totalling 18446744041753829712 bytes: Cannot allocate memory
    Traceback (most recent call last):
    File "/home/hpc/uj502/di29kiz/oases_0.2.8/scripts/oases_pipeline.py", line 121, in <module>
    main()
    File "/home/hpc/uj502/di29kiz/oases_0.2.8/scripts/oases_pipeline.py", line 115, in main
    singleKAssemblies(options)
    File "/home/hpc/uj502/di29kiz/oases_0.2.8/scripts/oases_pipeline.py", line 43, in singleKAssemblies
    assert p.returncode == 0, "Velvetg failed at k = %i\n%s" % (k, output[0])
    AssertionError: Velvetg failed at k = 35
    [0.000001] Reading roadmap file /naslx/projects/uj502/di29kiz/oases/LA2750_35/Roadmaps

    I have around 350 million paired reads. I'm working on a cluster that uses SLURM. Any recommendations? What should I do?
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    You're going to want to work with fewer reads than that...your cluster is trying to use 18 exabytes of memory, which it certainly doesn't have. Give digital normalization a try, for example with the tools from Titus Brown's group. That should heavily reduce the total number of reads to assemble and increase the overall assembly quality. Also, if you haven't already done so, make sure to quality/adapter trim the dataset.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-23-2026, 11:41 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    153 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    63 views
    0 reactions
    Last Post SEQadmin2  
    Working...